Across TCGA pan-cancer cohorts, LINC02647 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC02647 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02647 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02647 expression acts as an unfavorable survival marker.
LUAD, OV, and SARC are the cancer types where LINC02647 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.